Home
Scholarly Works
7014 A phase II study of sorafenib in combination...
Conference

7014 A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive Castrate Resistant Prostate Cancer (CRPC)

Authors

Beardsley EK; Hotte SJ; Ellard S; Winquist E; North S; Chi KN

Volume

7

Publisher

Elsevier

Publication Date

September 1, 2009

DOI

10.1016/s1359-6349(09)71392-8

Conference proceedings

European Journal of Cancer Supplements

Issue

2

ISSN

1359-6349

Contact the Experts team